Related Experiment Video
Updated: Mar 13, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
The DEAD-Box RNA Helicase DDX3 Interacts with NF-κB Subunit p65 and Suppresses p65-Mediated Transcription
Nian Xiang1, Miao He1, Musarat Ishaq1
1State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, P. R. China.
Abstract:
RNA helicase family members exhibit diverse cellular functions, including in transcription, pre-mRNA processing, RNA decay, ribosome biogenesis, RNA export and translation. The RNA helicase DEAD-box family member DDX3 has been characterized as a tumour-associated factor and a transcriptional co-activator/regulator. Here, we demonstrate that DDX3 interacts with the nuclear factor (NF)-κB subunit p65 and suppresses NF-κB (p65/p50)-mediated transcriptional activity. The downregulation of DDX3 by RNA interference induces the upregulation of NF-κB (p65/p50)-mediated transcription. The regulation of NF-κB (p65/p50)-mediated transcriptional activity was further confirmed by the expression levels of its downstream cytokines, such as IL-6 and IL-8. Moreover, the binding of the ATP-dependent RNA helicase domain of DDX3 to the N-terminal Rel homology domain (RHD) of p65 is involved in the inhibition of NF-κB-regulated gene transcription. In summary, the results suggest that DDX3 functions to suppress the transcriptional activity of the NF-κB subunit p65.
Insights
The RNA helicase DDX3 protein interacts with nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65, suppressing its transcriptional activity. DDX3 downregulation increases NF-κB-mediated transcription, impacting cytokine expression.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- RNA helicases, including the DEAD-box family member DDX3, are involved in numerous cellular processes.
- DDX3 is recognized as a tumor-associated factor and a regulator of transcription.
- Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a key transcription factor involved in immune responses and cancer.
Purpose of the Study:
- To investigate the interaction between DDX3 and NF-κB.
- To elucidate the role of DDX3 in regulating NF-κB transcriptional activity.
- To understand the molecular mechanism by which DDX3 affects NF-κB signaling.
Main Methods:
- Co-immunoprecipitation to assess DDX3-p65 interaction.
- RNA interference to downregulate DDX3 expression.
- Quantitative PCR and ELISA to measure NF-κB target gene and cytokine expression (IL-6, IL-8).
- Analysis of protein domains involved in the interaction.
Main Results:
- DDX3 directly interacts with the NF-κB subunit p65.
- Downregulation of DDX3 leads to increased NF-κB (p65/p50)-mediated transcription.
- Increased transcription correlates with elevated expression of downstream cytokines IL-6 and IL-8.
- The RNA helicase domain of DDX3 binds to the Rel homology domain (RHD) of p65, inhibiting transcription.
Conclusions:
- DDX3 acts as a suppressor of NF-κB (p65/p50)-mediated transcriptional activity.
- The interaction between DDX3 and p65 is crucial for regulating NF-κB target gene expression.
- DDX3's function in suppressing NF-κB signaling may have implications in cancer biology.
Related Concept Videos
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Types of RNA
RNA Performs Diverse...
NF-kB-dependent Signaling Pathway
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Abnormal Proliferation

